# Cannabis Clinical Updates May 2026: Latest Articles & Insights > **Author:** Benjamin Caplan, MD (ABFM Board Certified, MA Lic. #240562, NPI: 1962722637) > **Publisher:** CED Clinic (https://cedclinic.com) > **Canonical URL:** https://cedclinic.com/cannabis-clinical-updates-may-2026/ > **Published:** 2026-05-19T14:07:19-04:00 | **Last Modified / Clinically Audited:** 2026-09-28T10:06:06-04:00 > **Clinical Summary:** Explore cannabis clinical updates May 2026 with 10 new articles covering research, policy, and clinical relevance for practitioners and patients. --- In the Mix — Last 24 HoursMay 19, 2026. 10 articles reviewed below the CED clinical relevance threshold of 35. Listed in descending order of score. #28 [Erectile Dysfunction May Predispose Older Men to Multiple Types of Substance Abuse](https://www.medpagetoday.com/meetingcoverage/aua/121325) This article examines associations between erectile dysfunction and substance abuse patterns in older men, potentially relevant for clinicians assessing polydrug use in elderly cannabis patients. [Read more →](https://www.medpagetoday.com/meetingcoverage/aua/121325) #25 [Voices of Cannabis Europa: Jonathan Havens and Adam Fayne, Partners at Saul Erwing](https://businessofcannabis.com/voices-of-cannabis-europa-jonathan-havens-and-adam-fayne-partners-at-saul-erwing/) This article profiles cannabis industry partners discussing European institutional research opportunities and pharmaceutical development, potentially offering clinicians insights into international regulatory frameworks and research accessibility. [Read more →](https://businessofcannabis.com/voices-of-cannabis-europa-jonathan-havens-and-adam-fayne-partners-at-saul-erwing/) #25 [Vol. 72, No. 8, May 19, 2026 – Final Issue – Chiropractic Economics](https://www.chiroeco.com/portfolio/issue-8-of-chiropractic-economics-vol-72-no-8-may-19-2026/?amp) Article Summary This article discusses the endocannabinoid system’s role in metabolism and health, plus Health Savings Account strategies for chiropractors—topics of tangential interest to clinicians studying cannabinoid physiology. [Read more →](https://www.chiroeco.com/portfolio/issue-8-of-chiropractic-economics-vol-72-no-8-may-19-2026/?amp) #25 [Recreational weed brings in nearly $300 million a year in taxes. What if a Mass. ballot …](https://www.bostonglobe.com/2026/05/19/business/marijuana-taxes-cannabis-repeal-ballot-question/) Article discusses Massachusetts recreational marijuana tax revenue and a November ballot question that could eliminate it, potentially relevant to clinicians tracking policy impacts on cannabis availability and patient access. [Read more →](https://www.bostonglobe.com/2026/05/19/business/marijuana-taxes-cannabis-repeal-ballot-question/) #15 [Treatment delays rising among teens with cannabis use disorder – News-Medical.Net](https://www.news-medical.net/news/20260518/Treatment-delays-rising-among-teens-with-cannabis-use-disorder.aspx) Article Summary The article discusses cannabis use disorder treatment delays in adolescents and older adults’ edible consumption patterns for sleep, pain, and mood management. [Read more →](https://www.news-medical.net/news/20260518/Treatment-delays-rising-among-teens-with-cannabis-use-disorder.aspx) #15 [Researchers Develop High-Temperature Stable Hemp-Derived Plastic from CBD](https://hempgazette.com/news/high-temperature-stable-hemp-derived-plastic-cbd/) Summary Researchers created a thermally stable plastic material from hemp-derived CBD, demonstrating a non-medical application of [cannabis compounds](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/) that may interest clinicians tracking industrial cannabinoid utilization trends. [Read more →](https://hempgazette.com/news/high-temperature-stable-hemp-derived-plastic-cbd/) #15 [Is Tenet (THC) a Buy as Wall Street Analysts Look Optimistic? – Yahoo Finance](https://finance.yahoo.com/markets/stocks/articles/tenet-thc-buy-wall-street-133003934.html) The article discusses Wall Street analyst recommendations for Tenet (THC) stock, which may interest clinicians monitoring cannabis industry financial trends and market valuations. [Read more →](https://finance.yahoo.com/markets/stocks/articles/tenet-thc-buy-wall-street-133003934.html) #15 [In Business: Leech Lake Approves Band’s 1st Cannabis Cultivation Facility – Lakeland PBS](https://lptv.org/in-business-leech-lake-approves-bands-1st-cannabis-cultivation-facility/) Leech Lake Band approved its first cannabis cultivation facility, representing tribal regulatory development and potential implications for indigenous cannabis commerce and governance structures. [Read more →](https://lptv.org/in-business-leech-lake-approves-bands-1st-cannabis-cultivation-facility/) #15 [Convicted felon arrested after officers find PCP, nearly 20 pounds of marijuana – KTLA](https://ktla.com/news/inland-empire/san-bernardino-convicted-felon-pcp-marijuana/) Summary for Cannabis Clinician Law enforcement arrested a convicted felon during a traffic stop in San Bernardino with substantial marijuana quantities, illustrating cannabis seizure patterns in illicit drug enforcement operations. [Read more →](https://ktla.com/news/inland-empire/san-bernardino-convicted-felon-pcp-marijuana/) #5 [Vena Made a THC Seltzer for Coastal Girls That Will Absolutely Humble You – VICE](https://www.vice.com/en/via/vena-happy-tonix-thc-seltzers-review/) This article reviews a commercially available THC seltzer product, providing consumer feedback on potency and effects that may inform clinicians about market formulations and dosing presentations. [Read more →](https://www.vice.com/en/via/vena-happy-tonix-thc-seltzers-review/) Digest-Level Clinical Commentary Dr. Caplan’s Take These headlines reflect a field in transition where [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) is moving beyond anecdotal use toward legitimate clinical applications, particularly for older adults seeking alternatives to sedatives and opioids for pain and sleep, while simultaneously revealing persistent challenges around youth access, substance use disorder, and the need for rigorous treatment protocols. The commercial and legislative momentum, combined with emerging research on [cannabinoid pharmacology](https://cedclinic.com/cannabinoid-drug-interactions-clinical-evidence/) and novel delivery systems, suggests the next phase of [cannabis medicine](https://cedclinic.com/essential-oils-industrial-hemp-antimicrobial-benefits/) will require practitioners like myself to navigate between evidence-based dosing and patient expectations shaped by a largely unregulated consumer market. What strikes me most is the urgent gap between clinical need—particularly in geriatric populations and those with complex pain syndromes—and our current training infrastructure, which remains inadequate for the volume of patients now asking about cannabis as a therapeutic option. Clinical Perspective These items reflect several concurrent developments in cannabis use and policy: increasing normalization of cannabis products across diverse consumer demographics (including older adults seeking relief from pain and sleep disturbances), growing commercial infrastructure and tax revenue from legalized markets, and emerging research into both therapeutic applications and material science uses of [cannabis compounds](https://cedclinic.com/cannabis-terpene-synergy-entourage-effect/). The digest also suggests ongoing public health concerns, particularly regarding cannabis use disorder in younger populations and drug enforcement issues, indicating that regulatory expansion has not eliminated substance-related harms. Clinically, this landscape requires practitioners to develop competency in screening for cannabis use patterns across age groups, understanding the distinction between therapeutic and problematic use, and staying informed about evolving evidence on both risks and potential benefits. Policy[Medical Research](https://cedclinic.com/cb2-receptor-agonist-parkinsons/)Business & IndustryProduct DevelopmentRegulationPublic Health 💬 Join the Conversation Have a question about how this applies to your situation? [Ask Dr. Caplan →](https://benjamincaplan.com/ask-dr-caplan) Want to discuss this topic with other patients and caregivers? [Join the forum discussion →](https://cedclinic.com/interact/discussion-forums/forum/cannabis-industry/) Have thoughts on this? Share it: [𝕏 Share on X](https://twitter.com/intent/tweet?text=Just+read+this+on+CEDclinic.com%3A+In+the+Mix+%E2%80%94+May+19%2C+2026+%40drcaplan&url=)[in Share on LinkedIn](https://www.linkedin.com/sharing/share-offsite/?url=)[🦅 Share on BlueSky](https://bsky.app/intent/compose?text=Just+read+this%3A+In+the+Mix+%E2%80%94+May+19%2C+2026+--+via+%40drcaplan.bsky.social+)[📷 Follow on Instagram](https://www.instagram.com/drbenjamincaplan)[📝 Read more on Substack](https://doctorapprovedcannabis.substack.com/)[🔔 Subscribe via RSS](https://cedclinic.com/feed/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) Physician-Led, Whole-Person Care A doctor who takes the time to truly understand you. Personal care that starts with listening and is guided by experience and ingenuity. Health, Longevity, Wellness One-on-One Cannabis Guidance Metabolic Balance [Leave a Message](https://cedclinic.com/contact/) [Metabolic Care](https://cedclinic.com/metabolic/metabolic-how-it-works/) [Medical Consulting](https://cedclinic.com/book/) [Cannabis Care](https://cedclinic.com/book/) [https://cedclinic.com/contact/](https://cedclinic.com/contact/) RELATED READING AT CED CLINIC Continue exploring the evidence [In the Mix: 9 More Articles — May 06, 2026](https://cedclinic.com/mixed-cannabis-industry-articles-may-06-2026/) Review the previous set of cannabis clinical updates and research articles from early May 2026 for ongoing insights. [Read May 06 Update](https://cedclinic.com/mixed-cannabis-industry-articles-may-06-2026/) In the Mix: 10 More Articles — May 28, 2026 Explore the latest cannabis [clinical research](https://cedclinic.com/cannabis-based-therapies-smoking-cessation/) and policy developments from late May 2026. Read May 28 Update [In the Mix: 7 More Articles — May 19, 2026](https://cedclinic.com/mixed-cannabis-industry-articles-may-19-2026/) Additional cannabis clinical updates and research summaries from the same day provide complementary perspectives. [Read May 19 Additional](https://cedclinic.com/mixed-cannabis-industry-articles-may-19-2026/) ### Related --- ### Verification & Medical Governance - **Lead Clinical Author:** Benjamin Caplan, MD - **Credentials:** Board Certified in Family Medicine (ABFM), Former CMO Canna Care Docs (250,000+ patients supervised), Founder & CMO CED Clinic & CED Foundation, Author of *The Doctor-Approved Cannabis Handbook* (Penguin Random House). - **Clinical Scale:** 350,000+ lifetime evaluations overseen; 81,008-patient Real-World Evidence Registry (`~/.ced_rwe_vault.db`); 125,000+ peer-reviewed study literature observatory (`http://localhost:8768/api/explorer/terminal`). - **License Verification:** Commonwealth of Massachusetts License #240562 (https://checkahealthlicense.mass.gov/). - **NPI Registry:** 1962722637 (https://npiregistry.cms.hhs.gov/provider-view/1962722637). - **Ethics & Data Privacy:** Clinical registry observations adhere strictly to HIPAA Safe Harbor de-identification (45 CFR § 164.514(b)) and criteria for secondary research exemption under 45 CFR § 46.104(d)(4).